We are live on ! Find out more
DCM

DG Capital Management Portfolio holdings

AUM $326M
1-Year Est. Return 39.67%
This Fund
S&P 500
This Quarter Est. Return
+16.96%
1 Year Est. Return
+39.67%
3 Year Est. Return
+81.23%
5 Year Est. Return
+56.79%
10 Year Est. Return
–
AUM
$419M
AUM Growth
+$182M
Cap. Flow
+$118M
Cap. Flow %
28.25%
Top 10 Hldgs %
44%
Holding
139
New
103
Increased
12
Reduced
6
Closed
13

Top Buys

Rank Stock Value
1
DIN icon
Dine Brands
DIN
+$10M
2
AUPH icon
Aurinia Pharmaceuticals
AUPH
+$8.58M
3
ISPO
Inspirato
ISPO
+$8.07M
4
ATEX icon
Anterix
ATEX
+$8.05M
5
UTHR icon
United Therapeutics
UTHR
+$7.68M

Top Sells

Rank Stock Value
1
TVACU
Thayer Ventures Acquisition Corporation Units
TVACU
+$8.36M
2
PRVB
Provention Bio, Inc. Common Stock
PRVB
+$7.51M
3
FLACU
Frazier Lifesciences Acquisition Corporation Unit
FLACU
+$4.68M
4
BSX icon
Boston Scientific
BSX
+$4.16M
5
SCOAU
ScION Tech Growth I Unit
SCOAU
+$4.14M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 29.31%
2 Healthcare 16.91%
3 Financials 8.51%
4 Materials 4.27%
5 Consumer Staples 3.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
COOLU
126
DELISTED
Corner Growth Acquisition Corp. Unit
COOLU
– –
-150,000
Closed -$1.57M
RVLP
127
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
– –
-511,063
Closed -$2.11M
PRVB
128
DELISTED
Provention Bio, Inc. Common Stock
PRVB
– –
-443,331
Closed -$7.51M
AGRX
129
DELISTED
Agile Therapeutics
AGRX
– –
-110
Closed -$634K
SCOAU
130
DELISTED
ScION Tech Growth I Unit
SCOAU
– –
-400,000
Closed -$4.14M
FLACU
131
DELISTED
Frazier Lifesciences Acquisition Corporation Unit
FLACU
– –
-450,000
Closed -$4.68M
CRHC
132
DELISTED
Cohn Robbins Holdings Corp.
CRHC
– –
-100,549
Closed -$1.05M
TVACU
133
DELISTED
Thayer Ventures Acquisition Corporation Units
TVACU
– –
-800,000
Closed -$8.36M
TMTSU
134
DELISTED
Spartacus Acquisition Corporation Unit
TMTSU
– –
-50,000
Closed -$529K
NEBCU
135
DELISTED
Nebula Caravel Acquisition Corp. Unit
NEBCU
– –
-25,000
Closed -$270K
2 3 4 5
6

Similar funds

ECH
ER Collective Holdings Washington, District of Columbia $326M AUM
AFA
Alpha Financial Advisors Charlotte, North Carolina $326M AUM 15.49% 1-Year Est. Return
BCM
Boone Capital Management Atlanta, Georgia $326M AUM 86.31% 1-Year Est. Return
ISFAN
Investor's Fiduciary Advisor Network Snoqualmie, Washington $326M AUM 19.7% 1-Year Est. Return
JHWEPV
J. H. Whitney Equity Partners VI New Canaan, Connecticut $326M AUM
CCG
Ceeto Capital Group Coral Gables, Florida $326M AUM 24.81% 1-Year Est. Return
TC
TFR Capital Plano, Texas $326M AUM 24.24% 1-Year Est. Return
CWM
Chesapeake Wealth Management Williamsburg, Virginia $326M AUM 17.8% 1-Year Est. Return

DG Capital Management's Q1 2021 Portfolio in Review

As of Q1 2021, DG Capital Management held 139 positions worth $419M, up 77% from $236M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

DG Capital Management deployed $118M of net new capital in Q1 2021, opening 103 new positions and adding to 12 existing holdings. Its largest new stake was Dine Brands: 128,824 shares worth $11.6M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 29% of assets, up from 29% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was BioCryst Pharmaceuticals, an estimated $3.45M trimmed.

  • DG Capital Management's largest Q1 2021 buy was Dine Brands: 128,824 shares worth $11.6M.
  • DG Capital Management added most to United Therapeutics in Q1 2021, an estimated $7.68M increase.
  • DG Capital Management's biggest Q1 2021 reduction was BioCryst Pharmaceuticals, cutting an estimated $3.45M.
  • DG Capital Management fully exited Thayer Ventures Acquisition Corporation Units in Q1 2021, selling an estimated $8.36M.
  • DG Capital Management's ten largest holdings make up 44% of its $419M portfolio in Q1 2021.
  • DG Capital Management opened 103 new positions and closed 13 in Q1 2021.
  • DG Capital Management's portfolio value rose 77% quarter-over-quarter to $419M.

Based on DG Capital Management's 13F filing for Q1 2021, filed 13 May 2021.